Status:
COMPLETED
Decision Support for Detection of Chronic Kidney Disease in Type II Diabetes Mellitus
Lead Sponsor:
Brigham and Women's Hospital
Collaborating Sponsors:
Bayer
Conditions:
Chronic Kidney Diseases
Type2Diabetes
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
While data from the National Health and Nutrition Examination Survey (NHANES) estimate that 36.9% of patients with diabetes have CKD, only approximately 10% of patients are aware of their kidney disea...
Detailed Description
The study is a 400-patient single-center Quality Improvement Initiative in the form of a randomized controlled trial of an EPIC EHR BPA. The allocation ratio will be 1:1 for an EPIC BPA versus no noti...
Eligibility Criteria
Inclusion
- BWH outpatients at least 18 years of age who are evaluated in Primary Care or Brigham Medical Specialties Clinics (Cardiovascular Medicine, Endocrinology, and Diabetology) AND
- have a diagnosis of T2DM AND
- have not had a UACR measured in the past year
Exclusion
- have an established diagnosis of CKD (medical history, problem list, or visit diagnosis entry in the EHR) OR
- who are undergoing renal replacement therapy (either hemodialysis or peritoneal dialysis) as UACR will be unlikely to result in diagnosis change or therapeutic intervention OR
- who have undergone renal transplantation
Key Trial Info
Start Date :
December 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 30 2025
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT05342545
Start Date
December 1 2022
End Date
May 30 2025
Last Update
November 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Brigham and Women's Hospital
Boston, Massachusetts, United States, 02115